Amedisys (NASDAQ:AMED) Receives New Coverage from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research report report published on Sunday. The brokerage issued a buy rating on the health services provider’s stock. Separately, Cantor Fitzgerald lifted their target price on Amedisys from $100.00 to $101.00 and gave the stock a neutral rating in a report on […]